| Main purpose |
Broad gut health overview with an ecosystem view and personalized guidance. |
Gut microbiome assessment focused on intestinal/gut health insight. |
| Best for |
People who want practical, personalized nutrition and supplement next steps. |
People who want a gut microbiome snapshot and interpretation for general gut health. |
| Sample type |
Typically a stool sample (with dietary intake collected via a 3-day food diary). |
Typically a stool sample. |
| Analysis method |
16S DNA sequencing and Shotgun Metagenomics within its Gut Health Operating System. |
Not specified here; depends on the selected Gezonde Darmflora testing workflow. |
| What it measures |
Gut microbiome composition and related patterns used to interpret gut health and balance. |
Gut microbiome profile and interpretation toward gut health and balance markers. |
| Pathogens included? |
Typically focuses on broader ecosystem/balance; pathogen reporting may vary by report format. |
May include pathogen-related interpretation depending on how the report is structured. |
| Functional / microbiome balance insight |
Designed to provide ecosystem-level balance insight from microbiome data and diary context. |
Often provides balance/health interpretation based on microbiome findings. |
| Broad gut health overview |
Yes—positioned as a broad overview of gut health and the microbiome ecosystem. |
Yes—positioned as gut health-oriented microbiome interpretation. |
| Personalized recommendations |
Yes—includes personalized nutrition and personalized probiotic/prebiotic recommendations. |
Typically includes interpretation-based recommendations, with details varying by product/report. |
| Nutrition guidance included |
Yes—nutrition guidance is driven by a 3-day food diary and matched to results. |
Often includes general nutrition/lifestyle guidance, but level of personalization may differ. |
| Actionability of results |
High—action includes specific food items and daily dosage, plus supplement direction. |
Moderate—typically interpretive guidance; may be less granular than diary-to-dosage mapping. |
| Easy-to-understand report |
Consumer-friendly, designed to translate results into understandable next steps. |
Often designed for consumer use, but wording depth and framing may be more general. |
| Consumer-friendly vs clinician-focused |
More consumer-focused with clear translation into routines and recommendations. |
Typically consumer-oriented, though may vary by offering and report depth. |
| Suitable for ongoing monitoring |
Yes—DNA sequencing approaches are intended to support longitudinal comparisons over time. |
Often suitable for repeat testing, depending on the testing protocol used each time. |
| Turnaround time |
Not provided here; check current shipping/lab processing timelines. |
Not provided here; check current shipping/lab processing timelines. |
| Price |
Not provided here; check current pricing on the official InnerBuddies site. |
Not provided here; check current pricing on the official Gezonde Darmflora site. |
| Available in Europe / direct-to-consumer |
Available in Europe and direct-to-consumer. |
Likely available in Europe and direct-to-consumer, depending on the current offering. |
| Data privacy / EU friendliness |
Designed for EU consumers; details depend on the specific privacy policy and data handling practices. |
Designed to be used by consumers; EU privacy handling depends on the company’s specific policy. |